7-149879399-C-G

Variant summary

Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate

The NM_001289990.2(ATP6V0E2):​c.286C>G​(p.Pro96Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000712 in 1,600,656 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 11/16 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.000079 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000070 ( 0 hom. )

Consequence

ATP6V0E2
NM_001289990.2 missense

Scores

3
13

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 0.692
Variant links:
Genes affected
ATP6V0E2 (HGNC:21723): (ATPase H+ transporting V0 subunit e2) Multisubunit vacuolar-type proton pumps, or H(+)-ATPases, acidify various intracellular compartments, such as vacuoles, clathrin-coated and synaptic vesicles, endosomes, lysosomes, and chromaffin granules. H(+)-ATPases are also found in plasma membranes of specialized cells, where they play roles in urinary acidification, bone resorption, and sperm maturation. Multiple subunits form H(+)-ATPases, with proteins of the V1 class hydrolyzing ATP for energy to transport H+, and proteins of the V0 class forming an integral membrane domain through which H+ is transported. ATP6V0E2 encodes an isoform of the H(+)-ATPase V0 e subunit, an essential proton pump component (Blake-Palmer et al., 2007 [PubMed 17350184]).[supplied by OMIM, Mar 2008]
ATP6V0E2-AS1 (HGNC:44180): (ATP6V0E2 antisense RNA 1)

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 0 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.0737094).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ATP6V0E2NM_145230.4 linkc.*84C>G 3_prime_UTR_variant Exon 4 of 4 ENST00000425642.3 NP_660265.3 Q8NHE4-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ATP6V0E2ENST00000425642.3 linkc.*84C>G 3_prime_UTR_variant Exon 4 of 4 1 NM_145230.4 ENSP00000396148.2 Q8NHE4-1

Frequencies

GnomAD3 genomes
AF:
0.0000789
AC:
12
AN:
152180
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000241
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000196
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000118
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.0000812
AC:
19
AN:
233926
Hom.:
0
AF XY:
0.0000942
AC XY:
12
AN XY:
127356
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.0000933
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000131
Gnomad OTH exome
AF:
0.000358
GnomAD4 exome
AF:
0.0000704
AC:
102
AN:
1448476
Hom.:
0
Cov.:
32
AF XY:
0.0000667
AC XY:
48
AN XY:
720052
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.000116
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.0000814
Gnomad4 OTH exome
AF:
0.000100
GnomAD4 genome
AF:
0.0000789
AC:
12
AN:
152180
Hom.:
0
Cov.:
32
AF XY:
0.0000807
AC XY:
6
AN XY:
74340
show subpopulations
Gnomad4 AFR
AF:
0.0000241
Gnomad4 AMR
AF:
0.000196
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.000118
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.000226
Hom.:
0
Bravo
AF:
0.000110
ExAC
AF:
0.0000496
AC:
6

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Oct 26, 2021
Ambry Genetics
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

The c.364C>G (p.P122A) alteration is located in exon 3 (coding exon 3) of the ATP6V0E2 gene. This alteration results from a C to G substitution at nucleotide position 364, causing the proline (P) at amino acid position 122 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Benign
-0.37
T
BayesDel_noAF
Benign
-0.55
CADD
Benign
3.8
DANN
Uncertain
0.99
Eigen
Benign
-0.70
Eigen_PC
Benign
-0.82
FATHMM_MKL
Benign
0.11
N
LIST_S2
Benign
0.52
T;.;T;T
M_CAP
Benign
0.0041
T
MetaRNN
Benign
0.074
T;T;T;T
MetaSVM
Benign
-1.0
T
PrimateAI
Benign
0.35
T
PROVEAN
Benign
-0.44
.;N;N;.
REVEL
Benign
0.022
Sift
Uncertain
0.012
.;D;D;.
Sift4G
Uncertain
0.025
D;D;D;D
Polyphen
0.19
B;B;B;.
Vest4
0.10
MutPred
0.14
Loss of glycosylation at P122 (P = 0.0109);Loss of glycosylation at P122 (P = 0.0109);.;.;
MVP
0.18
MPC
0.60
ClinPred
0.042
T
GERP RS
1.1
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
gMVP
0.18

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs757772874; hg19: chr7-149576488; API